A Primer Of Drug Action: A Comprehensive Guide To The Actions, Uses, And Side Effects Of Psychoactive Drugs

Robert M. Julien

ISBN 10: 0716706156 / ISBN 13: 9780716706151

Published by Worth Pub, 2005

About this Item

10 edition. 690 pages. 9.00x6.00x1.25 inches. In Stock.

Seller Inventory # 0716706156

Bibliographic Details

• Title: A Primer Of Drug Action: A Comprehensive Guide To The Actions, Uses, And Side Effects Of Psychoactive Drugs
• Publisher: Worth Pub
• Publication Date: 2005
• Language: English
• ISBN 10: 0716706156
• ISBN 13: 9780716706151
• Binding: Paperback
• Condition: Brand New
• Weight: 0.98 kilograms

About this title

Synopsis

 A Primer of Drug Action addresses the mechanisms of action of each drug and drug class presented, current theories about the etiology of major psychological disorders and rationales for drug treatment, and the uses and limitations of psychopharmacology in patient care. Now in its Tenth Edition, this definitive guide has been completely revised and updated to again make it the most current and comprehensive introduction to the pharmacology of drugs that affect the mind and behavior.

About the Author

The Author
Robert M. Julien, M.D., received his M.S. and Ph.D. in Pharmacology from the University of Washington and his Medical Degree from the University of California at Irvine.  His many research articles focus on the psychopharmacology of sedative and antiepileptic drugs.  Previously an Associate Professor of Pharmacology and Anesthesiology at the Oregon Health Sciences University, he currently practices anesthesiology in Portland, Oregon. New Contributors
Claire D. Advokat, professor of psychology at LSU, received her Ph.D. from Rutgers University.  Her primary interest is in understanding the clinical effectiveness and the mechanism of action of drugs used in the treatment of mental illness, such as the antipsychotics, antidepressants, mood stabilizers, and anxiolytics. Joseph Comaty, Adjunct Professor at LSU, received his Ph.D. in clinical psychology from Rosalind Franklin University of Science and Medicine.  His primary area of research is clinical psychopharmacology.  In particular, he is interested in the study of the clinical treatment for the major psychiatric disorders of schizophrenia, major depression, and bipolar disorder.